Essential Thrombocythemia (ET)

Also known as: Essential Thrombocythemia / Essential Thrombocytosis / Thrombocythemia, Essential / Essential Thrombocythaemia / Thrombocythemias, Essential / Idiopathic thrombocytosis / Ideopathic thrombocytosis

DrugDrug NameDrug Description
DB01008BusulfanBusulfan is a bifunctional alkylating agent, having a selective immunosuppressive effect on bone marrow. It is not a structural analog of the nitrogen mustards. It has been used in the palliative treatment of chronic myeloid leukemia (myeloid leukemia, chronic), but although symptomatic relief is provided, no permanent remission is brought about. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), busulfan is listed as a known carcinogen. [PubChem]
DB01005HydroxyureaAn antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. [PubChem]
DrugDrug NamePhaseStatusCount
DB01169Arsenic trioxide1Terminated1
DB00928Azacitidine1Active Not Recruiting1
DB00958Carboplatin1Active Not Recruiting1
DB00987Cytarabine1Completed1
DB01262Decitabine1Active Not Recruiting1
DB00773Etoposide1Completed1
DB13040Gandotinib1Active Not Recruiting1
DB13040Gandotinib1Completed1
DB12325Idasanutlin1Recruiting1
DB00619Imatinib1Completed1
DB00008Peginterferon alfa-2a1Recruiting1
DB09143Sonidegib1Active Not Recruiting1
DB01268Sunitinib1Completed1
DB11941Tasisulam1Completed1
DB01030Topotecan1Active Not Recruiting1
DB07232Veliparib1Active Not Recruiting1
DB02546Vorinostat1Completed1
DB05243XL0191Terminated1
DB00041Aldesleukin1 / 2Completed1
DB11697Pacritinib1 / 2Completed1
DB08877Ruxolitinib1 / 2Active Not Recruiting1
DB09143Sonidegib1 / 2Active Not Recruiting1
DB00261Anagrelide2Completed1
DB00261Anagrelide2Recruiting1
DB00394Beclomethasone dipropionate2Completed1
DB01008Busulfan2Recruiting1
DB00958Carboplatin2Not Yet Recruiting1
DB00493Cefotaxime2Recruiting1
DB00531Cyclophosphamide2Recruiting3
DB00091Cyclosporine2Active Not Recruiting1
DB01073Fludarabine2Active Not Recruiting2
DB01073Fludarabine2Completed1
DB01073Fludarabine2Recruiting3
DB00619Imatinib2Completed1
DB00480Lenalidomide2Completed1
DB00563Methotrexate2Completed1
DB08893Mirabegron2Completed1
DB11763Momelotinib2Active Not Recruiting1
DB11763Momelotinib2Terminated1
DB00688Mycophenolate mofetil2Active Not Recruiting2
DB00688Mycophenolate mofetil2Recruiting3
DB01024Mycophenolic acid2Recruiting1
DB00635Prednisone2Completed1
DB08877Ruxolitinib2Active Not Recruiting1
DB08877Ruxolitinib2Recruiting1
DB00864Tacrolimus2Active Not Recruiting1
DB00864Tacrolimus2Completed1
DB00864Tacrolimus2Recruiting3
DB04572Thiotepa2Recruiting1
DB04960Tipifarnib2Completed1
DB01030Topotecan2Not Yet Recruiting1
DB11940Triapine2Completed1
DB07232Veliparib2Not Yet Recruiting1
DB02546Vorinostat2Unknown Status1
DB00261Anagrelide2 / 3Recruiting1
DB08877Ruxolitinib2 / 3Recruiting1
DB00261Anagrelide3Completed4
DB13900Equine Botulinum Neurotoxin A Immune FAB23Recruiting1
DB13903Equine Botulinum Neurotoxin B Immune FAB23Recruiting1
DB13898Equine Botulinum Neurotoxin C Immune FAB23Recruiting1
DB13902Equine Botulinum Neurotoxin D Immune FAB23Recruiting1
DB13897Equine Botulinum Neurotoxin E Immune FAB23Recruiting1
DB13901Equine Botulinum Neurotoxin F Immune FAB23Recruiting1
DB13899Equine Botulinum Neurotoxin G Immune FAB23Recruiting1
DB01005Hydroxyurea3Active Not Recruiting1
DB01005Hydroxyurea3Completed1
DB01005Hydroxyurea3Recruiting1
DB00008Peginterferon alfa-2a3Active Not Recruiting1
DB00022Peginterferon alfa-2b3Active Not Recruiting1
DB08877Ruxolitinib3Recruiting1
DB00261AnagrelideNot AvailableCompleted1
DB01008BusulfanNot AvailableCompleted1
DB00493CefotaximeNot AvailableCompleted1
DB00531CyclophosphamideNot AvailableCompleted1
DB00091CyclosporineNot AvailableCompleted1
DB01073FludarabineNot AvailableCompleted1
DB00529FoscarnetNot AvailableCompleted1
DB01004GanciclovirNot AvailableCompleted1
DB00563MethotrexateNot AvailableCompleted1
DB00688Mycophenolate mofetilNot AvailableCompleted1
DB00864TacrolimusNot AvailableCompleted1
DB01610ValganciclovirNot AvailableCompleted1